Rockwell Medical (Nasdaq: RMTI) grows Q2 2026 sales, tightens loss and reaffirms 2026 outlook
Rockwell Medical (RMTI) announced strong Q2 2026 results, with net sales increasing 11% year-over-year to $17.8 million and gross profit rising 30%. The company significantly narrowed its net loss to $1.2 million and generated positive operating cash flow of $2.1 million, strengthening its cash …